Oxford Asset Management LLP Buys 9,443 Shares of CVS Health Co. (NYSE:CVS)

Oxford Asset Management LLP raised its stake in CVS Health Co. (NYSE:CVS - Free Report) by 110.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,999 shares of the pharmacy operator's stock after acquiring an additional 9,443 shares during the quarter. Oxford Asset Management LLP's holdings in CVS Health were worth $808,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CVS. Norges Bank acquired a new position in shares of CVS Health during the fourth quarter valued at about $839,574,000. Capital World Investors grew its holdings in CVS Health by 26.6% during the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after buying an additional 12,819,148 shares in the last quarter. Davis Selected Advisers raised its position in CVS Health by 2,998.1% in the 4th quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator's stock valued at $511,115,000 after buying an additional 11,018,438 shares during the last quarter. Dodge & Cox boosted its holdings in CVS Health by 11.2% during the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock worth $3,147,054,000 after acquiring an additional 7,075,209 shares during the last quarter. Finally, Pzena Investment Management LLC grew its position in CVS Health by 49.3% in the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after purchasing an additional 6,475,271 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Michael F. Mahoney purchased 30,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares of the company's stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP James David Clark sold 7,513 shares of the company's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now owns 8,394 shares in the company, valued at $556,941.90. The trade was a 47.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.22% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Evercore ISI boosted their price objective on CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research report on Monday, January 27th. StockNews.com upgraded shares of CVS Health from a "sell" rating to a "hold" rating in a research report on Thursday, February 13th. Wells Fargo & Company lifted their price objective on shares of CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Barclays lifted their price target on shares of CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. Finally, Piper Sandler raised their target price on CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research report on Friday, March 21st. Four analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and an average price target of $71.83.

CVS Health Trading Up 2.5 %

Shares of CVS traded up $1.62 during mid-day trading on Wednesday, reaching $66.65. The company's stock had a trading volume of 12,514,615 shares, compared to its average volume of 11,193,539. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The stock has a market cap of $84.03 billion, a PE ratio of 18.21, a P/E/G ratio of 0.98 and a beta of 0.57. The company's fifty day moving average price is $66.45 and its two-hundred day moving average price is $58.74. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $71.45.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.99%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health's payout ratio is 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.